These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25511318)

  • 1. Histidine-tryptophan-ketoglutarate solution with added ebselen augments myocardial protection in neonatal porcine hearts undergoing ischemia/reperfusion.
    Chen Y; Liu J; Li S; Yan F; Xue Q; Wang H; Sun P; Long C
    Artif Organs; 2015 Feb; 39(2):126-33. PubMed ID: 25511318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which is the better option during neonatal cardiopulmonary bypass: HTK solution or cold blood cardioplegia?
    Chen Y; Liu J; Li S; Li W; Yan F; Sun P; Wang H; Long C
    ASAIO J; 2013; 59(1):69-74. PubMed ID: 23263337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia--an experimental comparative study in pigs.
    Aarsaether E; Stenberg TA; Jakobsen Ø; Busund R
    Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):635-9. PubMed ID: 19628529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial protection in donor heart preservation: a comparison between Bretschneider's histidine-tryptophan-ketoglutarate solution and cold blood cardioplegia.
    Sung SY; Lin CY; Song JY; Tsai YT; Kao CH; Lee CY; Lin YC; Hsu PS; Tsai CS
    Transplant Proc; 2014 May; 46(4):1077-81. PubMed ID: 24815133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclosporine A-enhanced cardioplegia preserves mitochondrial basal respiration after ischemic arrest.
    Hoyer AA; Klaeske K; Garnham J; Kiefer P; Salameh A; Witte K; Borger M; Dieterlen MT
    Perfusion; 2024 Jan; 39(1):36-44. PubMed ID: 34192950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection.
    Arslan A; Sezgin A; Gultekin B; Ozkan S; Akay T; Uguz E; Tasdelen A; Aslamaci S
    Transplant Proc; 2005 Sep; 37(7):3219-22. PubMed ID: 16213352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficiency of heart protection with HTK or HTK-N depending on the type of ischemia.
    Schaefer M; Gebhard MM; Gross W
    Bioelectrochemistry; 2019 Feb; 125():58-69. PubMed ID: 30265864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogen as additive of HTK solution fortifies myocardial preservation in grafts with prolonged cold ischemia.
    Tan M; Sun X; Guo L; Su C; Sun X; Xu Z
    Int J Cardiol; 2013 Jul; 167(2):383-90. PubMed ID: 22264873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nitric oxide donor, S-nitroso human serum albumin, as an adjunct to HTK-N cardioplegia improves protection during cardioplegic arrest after myocardial infarction in rats.
    Trescher K; Dzilic E; Kreibich M; Gasser H; Aumayr K; Kerjaschki D; Pelzmann B; Hallström S; Podesser BK
    Interact Cardiovasc Thorac Surg; 2015 Mar; 20(3):387-94. PubMed ID: 25468794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New HTK-N46B cardioplegia provides superior protection during ischemia/reperfusion in failing hearts.
    Trescher K; Hasun M; Baumgartner A; Dietl W; Wolfsberger M; Hallström S; Podesser BK
    J Cardiovasc Surg (Torino); 2013 Jun; 54(3):413-21. PubMed ID: 23389583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary oxygen persufflation combined with HTK cardioplegia prolongs the preservation time in heart transplantation.
    Kuhn-Régnier F; Fischer JH; Jeschkeit S; Switkowski R; Bardakcioglu O; Sobottke R; de Vivie ER
    Eur J Cardiothorac Surg; 2000 Jan; 17(1):71-6. PubMed ID: 10735415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Astragalin and dihydromyricetin as adjuncts to histidine‑tryptophan‑ketoglutarate cardioplegia enhances protection during cardioplegic arrest.
    Wang D; Zhang X; Qu D; Han J; Meng F; Xu M; Zheng Q
    Mol Med Rep; 2018 Sep; 18(3):2929-2936. PubMed ID: 30015889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of HTK solution for myocardial preservation.
    Hachida M; Ookado A; Nonoyama M; Koyanagi H
    J Cardiovasc Surg (Torino); 1996 Jun; 37(3):269-74. PubMed ID: 8698763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardioprotective effects of low-dose cyclosporin A added to histidine-tryptophan-ketoglutarate cardioplegia solution prior to total myocardial ischemia: an in vitro rabbit heart study.
    Pritzwald-Stegmann P; Hoyer A; Kempfert J; Dhein S; Mohr FW
    Pharmacology; 2011; 88(3-4):167-73. PubMed ID: 21952163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients.
    Careaga G; Salazar D; Téllez S; Sánchez O; Borrayo G; Argüero R
    Arch Med Res; 2001; 32(4):296-9. PubMed ID: 11440787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eight hours of cold static storage with adenosine and lidocaine (Adenocaine) heart preservation solutions: toward therapeutic suspended animation.
    Rudd DM; Dobson GP
    J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1552-61. PubMed ID: 21742347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histidine-tryptophan-ketoglutarate solution decreases mortality and morbidity in high-risk patients with severe pulmonary arterial hypertension associated with complex congenital heart disease: an 11-year experience from a single institution.
    Li XW; Lin YZ; Lin H; Huang JB; Tang XM; Long XM; Lu WJ; Wen ZK; Liang J; Li DY; Zhao XF
    Braz J Med Biol Res; 2016; 49(6):e5208. PubMed ID: 27191607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Assessment of Histidine-Tryptophan-Ketoglutarate Solution and Modified St. Thomas' Solution in Pediatric Cardiac Surgery of Tetralogy of Fallot.
    Wang ZH; An Y; Du MC; Qin TJ; Liu YB; Xu HZ; Yang LQ
    Artif Organs; 2017 May; 41(5):470-475. PubMed ID: 27878830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of terminal warm blood cardioplegia in combination with Bretschneider-HTK solution for myocardial protection].
    Morishita A; Kitamura M; Ishitoya H; Hachida M; Endoh M; Koyanagi H
    Kyobu Geka; 1999 Sep; 52(10):831-5. PubMed ID: 10478544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Analysis of Myocardial Protection with HTK Solution and Hypothermic Hyperkalemic Blood Solution in the Correction of Acyanogenic Congenital Cardiopathies - A Randomized Study.
    Valente AS; Lustosa GP; Mota LAM; Lima A; Mesquita FA; Gondim A; Rodrigues FA; Pompeu RG; Branco KC
    Braz J Cardiovasc Surg; 2019 Jun; 34(3):271-278. PubMed ID: 31310464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.